Author: 24ChemicalResearch

The global reverse transcriptase market, valued at USD 316 million in 2024, is projected to rise to USD 417 million by 2031, advancing at a CAGR of 4.1% over the forecast period

Reverse transcriptase market, is projected to grow steadily and reach USD 417 million by 2031, registering a CAGR of 4.1% during the forecast period.

Chlorhexidine Gluconate API Market is poised for sustained growth, rising from USD 137 million in 2024 to USD 176 million by 2031, registering a 3.8% CAGR during the forecast period.

The global Human Neuregulin Molecule Market, valued at USD 202 million in 2024, is poised for consistent growth, expanding from USD 213 million in 2025 to USD 289 million by 2031, at a CAGR of 5.4%.

Autoimmune disease drugs market is poised for steady expansion, projected to grow from USD 134.92 billion in 2025 to USD 169.34 billion by 2031 at a 3.9% CAGR.

Non-Receptor Tyrosine Kinase Inhibitors (NRTKI) Market is projected to grow from USD 8.45 billion in 2025 to USD 15.02 billion by 2031, registering a strong CAGR of 9.6% during the forecast period.

Prostacyclin market is projected to reach USD 3.86 billion by 2031, expanding at a CAGR of 7.7% during the forecast period (2025–2032).

Global Sugar Coated Tablets Market, is projected to reach USD 1,695 million by 2031, registering a CAGR of 1.6% during the forecast period (2025–2031).

Rifabutin market, valued at USD 284.7 million in 2024, is projected to grow to USD 433.8 million by 2032, registering a robust CAGR of 5.3% during the forecast period.